Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System-Reference-Cited by-同舟云学术

Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System

Published:2021-07-01 Issue:7 Volume:31 Page:1056-1066
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Corrado Alda¹,Aceto Romina¹²,Silvestri Roberto¹,Dell'Anno Irene¹,Ricci Benedetta³,Miglietta Simona⁴,Romei Cristina⁵,Giovannoni Roberto¹,Poliseno Laura⁶,Evangelista Monica⁶,Vitiello Marianna⁶,Cipollini Monica¹,Garritano Sonia⁷,Giusti Laura⁸,Zallocco Lorenzo⁹¹⁰,Elisei Rossella⁵,Landi Stefano¹,Gemignani Federica¹

Affiliation:

1. Genetic Unit, Department of Biology, University of Pisa, Pisa, Italy.

2. Humanitas Clinical and Research Centre-IRCCS, Milan, Italy.

3. Fondazione I.R.C.C.S., Istituto Neurologico Carlo Besta, Milan, Italy.

4. San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.

5. Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

6. Institute of Clinical Physiology (IFC), CNR, Pisa, Italy.

7. Centre for Integrative Biology, University of Trento, Trento, Italy.

8. School of Pharmacy, University of Camerino, Camerino, Italy.

9. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.

10. Department of Pharmacy, University of Pisa, Pisa, Italy.

Publisher